CCL2 and autoimmune disease: It has been reported that in autoimmune diseases, the formation of an inflammatory microenvironment induces the production of CCL2 in response to inflammatory cytokines such as IL‐1β, which recruits and expands macrophage aggregation at the site of inflammation [32, 33].